Vanguard Capital Management
CLBT icon

Vanguard Capital Management’s Cellebrite CLBT Stock Holding History

Vanguard Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.67K Buy
+251
New +$3.32K ﹤0.01% 4073

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Vanguard Capital Management's CLBT Position: Q2 2026 in Review

Vanguard Capital Management opened a new position in Cellebrite (CLBT) in Q2 2026: 251 shares worth $3.67K. The stake represents ﹤0.01% of the portfolio and ranks #4073 among its holdings.

200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Vanguard Capital Management held 251 shares of Cellebrite worth $3.67K as of Q2 2026.
  • Cellebrite was a new Vanguard Capital Management position in Q2 2026.
  • Cellebrite made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #4073 holding.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.